News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment interruptions news

Show

From To
Resistance
ICAAC: In NNRTI-based regimens, stepwise discontinuation minimises risk of antiretroviral resistance

Stopping NNRTI treatment seven to ten days before stopping the nucleoside analogue backbone does minimise the risk of developing NNRTI resistance, a Thai study has

Published
19 September 2007
By
Derek Thaczuk
Treatment interruptions
IAS: ART interruption particularly unsafe for HIV-positive patients coinfected with hepatitis B or C

Intermittent interruption of antiretroviral therapy appeared particularly unsafe for HIV-positive people coinfected with hepatitis B or C in the SMART study, researchers reported on Tuesday

Published
24 July 2007
By
Liz Highleyman
HIV treatment
Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated

The license for nelfinavir (Viracept) has been temporarily suspended by European drug regulatory authorities. The move comes two weeks after it was discovered that

Published
21 June 2007
By
Michael Carter
HIV treatment
Near-global nelfinavir (Viracept) recall 'very difficult situation'

On June 14th, WHO issued a statement on the recall, saying that "Roche informed WHO on 8 June 2007 of its global recall of its

Published
20 June 2007
By
Edwin J. Bernard
Transmission and prevention
CROI: SMART substudy finds people on treatment less likely to transmit HIV, and may take fewer risks

A substudy of sexually transmitted infections and sexual risk-taking among participants in the large SMART study of structured treatment interruptions has found that people on

Published
04 March 2007
By
Gus Cairns
Side-effects
CROI: SMART analysis reveals slightly elevated risk of cardiovascular disease in people who interrupt therapy

The latest analysis of data from the SMART study suggest that HIV-positive people who periodically interrupt therapy based on CD4 cell counts have a slightly

Published
27 February 2007
By
Liz Highleyman
Treatment interruptions
Studies finds risks in guided treatment interruptions even at higher CD4 cell threshold

A study published in the January 11th edition of AIDS found that “guided treatment interruptions” in people with CD4 cell counts greater than 350 cells/mm3

Published
01 February 2007
By
Derek Thaczuk
Side-effects
Asthma drug provides effective treatment for immune reconstitution inflammatory syndrome

A drug normally used to treat asthma provided an effective treatment for antiretroviral-associated immune reconstitution inflammatory syndrome, investigators from one of London’s leading HIV treatment

Published
31 January 2007
By
Michael Carter
Changing treatment
One-in-six interrupt treatment within two years of initiating ART

CD4 count-guided treatment interruptions as a long-term HIV treatment strategy have been extensively discussed in recent months, after the early discontinuation of the SMART study

Published
18 September 2006
By
Edwin J. Bernard
Treatment interruptions
SMART study - treatment breaks lower quality of life

HIV-positive individuals in the SMART study who were in the treatment conservation arm experienced a significant decline in quality of life as the study progressed,

Published
28 August 2006
By
Michael Carter
← Prev1...23456...7Next →

Filter by country